KNOWLEDGE BANK

Interviews

University of Lincoln, UK

Senior Lecturer, School of Pharmacy
Ishwar Singh is a Senior Lecturer in Biological Chemistry at the School of Pharmacy University of Lincoln Prior to Lincoln he had held many prestigious fellowships such as the Alexander von Humboldt fellowship Germany and Senior Research Fellowship DANIDA Denmark and CSIR India He is an organic chemist He has developed bioconjugations for DNA RNA and polymer modifications in water He is currently...

Articles

Current Challenges in Fully Digitising Manufacturing for Biotech and Cell and Gene Therapy Companies

Cell and gene therapy are emerging treatments for genetic diseases and cancers No doubt that the biotech industry is growing exponentially at per cent CAGR It is expected to reach around USbn by However biotech companies that manufacture such CGT treatments still operate manually and face challenges such as unscalability human judgement errors

Research Insights

Identification of Circulating miRNAs as Fracture-related Biomarkers

Fracture nonunions affect many patients leading to functional and psychosocial disability Several risk factors have been described and include biological surgical and mechanical factors However none of them are able to determine

Case Studies

Glucose Oxidase Stabilised in OxyzymeT - a commercial wound dressing

Partner nsense Ltd is a specialty wound care company that has developed a range of novel active hydrogelbased dressings OxyzymeT and IodozymeT which are capable of active delivery of oxygen iodine and nitric oxide to a wound site

Techno Trends

Japan's Ministry of Health Announces New Clinical Trial Guidelines Focusing on Data Integrity

New guidelines from Japans Ministry of Health emphasize the importance of data integrity in clinical trials potentially reshaping research methodologies

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Labelling and imaging of Radiopharmaceuticals

Sumel Ashique

Sumel Ashique has been working as an assistant professor in Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 50+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 4 granted patents from IP and Australia, 8 published book chapters in International Books and 12 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 5 books under CRC; AAP, Springer and Wiley publisher

 

Radheshyam Pal

Radheshyam Pal is an Assistant Professor at Pandaveswar School of Pharmacy. His areas of expertise in Neuropharmacology. He specifically works on the role of natural products in the CNS. He has 2 years of teaching experience. He has 2 patents and also 10 book chapters submitted in international publisher.

 

2

Use of Steroids in COVID-19 patients

Anoop Kumar

Anoop Kumar currently working as Assistant Professor in Department of Pharmacology and Clinical Research, Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, India. He has authored more than 70 research and review articles and 10 book chapters in International Journal of repute. His research interests are Drug repurposing, Meta-analysis, Risk and benefit analysis of drugs and Pharmacoeconomic studies.

 

3

Advancing Automation and Digitalization in the Industrial Microbiology Workflow

Brad Grobler

Brad is Head of Biomonitoring Strategic Initiatives, which includes development and execution of  the Digital strategy in Robotics & Automation, eBusiness, Informatics and the Biomonitoring Ecosystem. Throughout his 10 years at the company, Brad has been engaged in Commercial, Operation and Strategy with regional and global focus.

 

4

The Green Revolution in Medicine

Aishwarya Jain

Dr Aishwarya Jain is an Assistant Professor and award-winning pharmaceutical researcher recognised with over 70+ national and international honours. Her research focuses on green synthesis, nanotechnology, and sustainable drug delivery. A SCOPUS journal editor and published author, she is dedicated to advancing eco-friendly pharmaceutical innovation and inspiring the next generation of researchers.

5

APAC’s Rising Role in Neurodegenerative Disease Research and Development

Simona Lambertini

Simona Lambertini is a senior global clinical research leader with nearly 20 years of experience in international clinical development, research strategy and stakeholder engagement. She has led complex multicountry programs across Europe, North America and the Middle East, collaborating with pharma, biotech and research institutions across high-complexity therapeutic areas.

press releasesRead more...

Lotus Pharmaceutical Announces Acquisition of a Specialty Pharmaceutical Product in South Korea, Expanding Portfolio in Urology and Infectious Disease Prevention

Lotus Pharmaceutical Co Ltd a global pharmaceutical company headquartered in Taiwan today announced that it has entered into an agreement with OM Pharma a global biopharmaceutical company headquartered

FUJIFILM Cellular Dynamics Launches New iPSC Manufacturing Facility in Madison

FUJIFILM Cellular Dynamics Inc a pioneering global developer and manufacturer of humaninduced pluripotent stem cells iPSCs today celebrated the opening of its new headquarters and iPSC development

Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma

Shanghai Junshi Biosciences Co Ltd Junshi Biosciences HKEX SSE a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies

Polpharma Biologics and Tuteur sign a licensing agreement for a biosimilar targeting autoimmune diseases

Polpharma Biologics a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars today announced the signing of a landmark licensing agreement with Argentinabased Tuteur

Innovent and HUTCHMED Receive NMPA Approval for TYVYT® and ELUNATE® Combination Therapy in Advanced Renal Cell Carcinoma

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of cancer metabolic autoimmune and other major diseases

Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery

Incyte and Genesis Molecular AI today announced a significant expansion of their strategic collaboration building and deploying stateoftheart AI to accelerate the discovery of novel molecules for collaboration targets selected by Incyte

EventsRead more...

27 - 28

May 2026

Digi-Tech Pharma & AI Conference

London, United Kingdom

27 - 28

May 2026

27 - 28

May 2026

UK Biotech Day

Radisson Hotel & Conference Centre London Heathrow, UK

27 - 28

May 2026

Future Labs Live 2026

Congress Center, Basel, Switzerland

01 - 02

Jun 2026

Future Pharma 2026

Renaissance Seaport District, Boston, MA, USA

02 - 04

Jun 2026

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia, USA

04 - 05

Jun 2026

Pharmac South 2026

Chennai Trade Centre, Nandambakkam, India

04 - 05

Jun 2026

LATEST NEWSRead more...

Bristol Myers Squibb Enters into Agreement with Anthropic for AI Deployment Across Global Operations

Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy Claude Enterprise across its global operations

Engage Bio Acquired by Lilly to Advance Non-Viral Genetic Medicines

Engage Biologics has been acquired by Eli Lilly and Company to support the development of nonviral genetic medicines

Exelixis and Merck Collaborate on Phase 3 Trial for Colorectal Cancer Treatment

Exelixis has announced a clinical development collaboration with Merck for the Phase STELLAR pivotal trial in patients with colorectal cancer CRC

AstraZeneca and Daiichi Sankyo Expand ENHERTU Use in Early HER2-Positive Breast Cancer in the US

AstraZeneca and Daiichi Sankyo have received approval from the US Food and Drug Administration for the use of Enhertu trastuzumab deruxtecan in both neoadjuvant and adjuvant treatment settings for patients with HERpositive early breast cancer

Regeneron and Parabilis Partner to Develop Antibody-Helicon Conjugates Across Multiple Therapeutic Areas

Regeneron Pharmaceuticals has announced a strategic research collaboration with Parabilis Medicines to discover and develop therapeutic candidates using Parabilis Helicon peptide platform

Elabscience Launches PolyHRP-Streptavidin Conjugate for ELISA Testing

Elabscience has launched a selfdeveloped PolyHRPStreptavidin conjugate designed to improve the sensitivity of enzymelinked immunosorbent assay ELISA testing for lowabundance biomarker detection